| Drug General Information |
| Drug ID |
D0M0XB
|
| Former ID |
DCL000368
|
| Drug Name |
AZD0530
|
| Synonyms |
Saracatinib; H8H; AZD-0530; Saracatinib, AZD-0530, AZD0530; N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine; 4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline
|
| Drug Type |
Small molecular drug
|
| Therapeutic Class |
Anticancer Agents
|
| Company |
AstraZeneca
|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C27H32ClN5O5
|
| InChI |
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
|
| InChIKey |
OUKYUETWWIPKQR-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
15309164, 17422546, 21317858, 22676280, 41368296, 46394234, 46512739, 50076463, 52589432, 57374518, 85197643, 85246182, 92721419, 99431771, 103501598, 109692957, 118844934, 124490404, 124756929, 124950158, 125163736, 125349317, 126619163, 126660092, 126666998, 131312788, 131465100, 134339018, 134344133, 135252487, 135686054, 135686055, 135686076, 135686077, 135727436, 136368072, 136920278, 136946508, 137185244, 137275842, 141775073, 144115661, 152258141, 152344117, 160646980, 162011430, 162037380, 162200062, 163884828, 164042932
|
| Target and Pathway |
| References |
